November 5 - 9, 2015
Hynes Convention Center
Boston, Massachusetts, USA
Abstract submission deadline: Thursday, September 24
Professional Educational Grants:
Assistance for Attendees with DisabilitiesThis AACR-NCI-EORTC conference is accessible to all registrants. Attendees with special requirements for transportation, hotel accommodations, or other facilities associated with the conference should notify the AACR in advance when registering or by emailing
Career Mentoring SessionSponsored by
Women in Cancer Research (WICR)November 7, 20156:00 p.m.-8:00 p.m.
This session has been designed for graduate students, medical students and residents, and clinical and postdoctoral fellows. Following a keynote address, attendees will meet, network, and learn from many of the leading senior scientists in cancer research. Topics include careers in industry, writing a CV, careers in translational research, mentoring and supervising, and many more. Although all conference attendees are invited to attend this session, it is geared toward early-career female investigators.
Only conference registrants may participate in this session. Onsite registration will be available on a first-come, first-served basis.Seating is limited. Contact
firstname.lastname@example.org with any questions and to learn more about
Women in Cancer Research (WICR).
PressMembers of the national and international media depend on the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference to provide the most up-to-date information on drug development in oncology. At this year’s conference, the American Association for Cancer Research (AACR) Communications and Public Relations Department will be conducting a press program and staffing a press room. Reporters and PIOs from medical centers who are interested in registering for the conference should contact Lauren Riley at
email@example.com. The AACR does not release media lists, but will make available company-sponsored press releases on abstract presentations in the press room. For more information on the Molecular Targets and Cancer Therapeutics press program contact Jeff Molter at 267-210-3965 or
firstname.lastname@example.org, Julia Gunther at 215-446-6896 or
email@example.com, or Lauren Riley at 215-446-7155 or
LocationThe conference will be held at the John B. Hynes Veterans Memorial Convention Center (the Hynes Convention Center), located in Boston’s Back Bay area. The Center is conveniently located close to public transportation for easy access by Boston’s “T” subway system and commuter rails. In many ways, the Hynes Convention Center is a city within a city. The Hynes is connected to not one, but two major retail complexes—Prudential Center and Copley Place—that contain just about everything attendees need during the conference. Fast food, fine dining, sundries, personal services, and world-class shopping - all under one roof. Attendees can experience Boston without ever worrying about the weather! Enter the Prudential Center through the Hynes South Lobby. Turn right for the Sheraton Boston Hotel, Starbucks, dining, and business center. A left turn leads to the Prudential Center, home to an extensive food court and fine dining, as well as boutiques and shops including Saks Fifth Avenue and Lord & Taylor.
Boston attractions provide more compelling things to see and do than any other convention city in North America. From America’s history found along the Freedom Trail to world-famous museums and international cuisine. The Theater District, located only minutes from the Hynes Center, hosts Broadway plays and musicals. Jazz clubs, dance clubs, comedy clubs, and improv theaters add to the entertainment scene. And for those who consider shopping to be the ultimate entertainment, Boston offers the boutiques of Newbury Street and the shops at Quincy Market.
Code of Conduct, Policies, and ProceduresThe AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference brings together an estimated 3,000 academics,scientists, and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, targetselection, and the impact of new discoveries in molecular biology. In order for all participants to have the opportunity to gainthe most benefit from this conference, the AACR is committed to providing a safe and secure environment. Please review thefollowing Code of Conduct, Policies, and Procedures for Conference Participants. By registering for the 2015 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference, you agree to the following terms: